Taipei, Monday, August 21, 2017 10:32 (GMT+8)
scattered thunderstorms
Taipei
33°C
PCB maker Apex to see capacity utilization rate drop to 80% in 4Q12 - related company info
Ingrid Lee, Taipei; Steve Shen, DIGITIMES [Thursday 11 October 2012]
  • Apex Biotechnology
  • Performance
    The company's stock price closed at NT$34.9 on the TSE on Friday, August 18, 2017.
    The company has reported consolidated revenues of NT$179 million for July 2017, representing a 16.7% increase on month and 19.1% increase on year.
    For the second quarter of 2017, the company totaled NT$420 million in consolidated revenues, down 1.2% sequentially and down 17.5% on year.
    Brief

    Full name: Apex Biotechnology

    Chinese name: 五鼎生物技術股份有限公司

    Short name: Apex

    Stock code: 1733

    Tax ID: 16130182

    Market: TSE

    Established: 2 Dec 1997

    Paid in capital: NT$985.31 million

    Listed on TSE: 17 Sep 2001

    Website: www.apexbio.com

  • Latest stock
    Apex [1733] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    21-Aug 66   34.90 35.10 34.75 35.00+0.10+0.29%  
    18-Aug 208 152 7,236,400 34.80 35.05 34.50 34.90+0.00+0.00% 34.90 34.95
    17-Aug 332 225 11,484,050 34.00 35.00 34.00 34.90+1.00+2.95% 34.90 34.95
    16-Aug 98 64 3,330,850 34.00 34.20 33.80 33.90+0.10+0.30% 33.85 33.90
    15-Aug 106 51 3,597,200 34.50 34.50 33.65 33.80+0.25+0.75% 33.70 33.80
    14-Aug 219 115 7,356,299 33.60 34.00 33.30 33.55-0.05-0.15% 33.55 33.60
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, Jul 2016 - Jul 2017 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Jul-17

    179

    16.7%

    19.1%

    1,024

    (10.3%)

    Jun-17

    153

    17.6%

    (4.5%)

    845

    (14.8%)

    May-17

    130

    (4.6%)

    (21.7%)

    692

    (16.7%)

    Apr-17

    136

    (22.2%)

    (25.2%)

    561

    (15.5%)

    Mar-17

    175

    77.6%

    (6.2%)

    425

    (11.8%)

    Feb-17

    99

    (34.6%)

    (25.8%)

    250

    (15.4%)

    Jan-17

    151

    27.1%

    (6.9%)

    151

    (6.9%)

    Dec-16

    119

    (14%)

    (14%)

    1,786

    (3.4%)

    Nov-16

    138

    2.8%

    (16.2%)

    1,667

    (2.5%)

    Oct-16

    134

    2.7%

    (24%)

    1,529

    (1%)

    Sep-16

    131

    7.1%

    (17.1%)

    1,394

    1.9%

    Aug-16

    122

    (18.5%)

    (18.9%)

    1,263

    4.4%

    Jul-16

    150

    (6.4%)

    (7.4%)

    1,141

    7.8%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, August 2017

    Apex: Consolidated revenues, 2Q16 - 2Q17 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    2Q-17

    420

    (1.2%)

    (17.5%)

    845

    (14.8%)

    1Q-17

    425

    15.2%

    (11.8%)

    425

    (11.8%)

    4Q-16

    369

    (8.5%)

    (23.1%)

    1,763

    (4.6%)

    3Q-16

    403

    (20.8%)

    (14.3%)

    1,394

    1.9%

    2Q-16

    509

    5.6%

    20.4%

    991

    10.5%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, August 2017

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 2Q16 - 2Q17 (NT$k)

    Item

    2Q-2017

    1Q-2017

    4Q-2016

    3Q-2016

    2Q-2016

    Current assets

    1,632,388

    1,647,085

    1,602,788

    1,783,928

    1,758,668

    Intangible assets

    314,386

    25,010

    25,854

    26,609

    27,768

    Non-current assets

    1,143,758

    880,663

    897,998

    1,075,070

    1,093,237

    Assets

    2,776,146

    2,527,748

    2,500,786

    2,858,998

    2,851,905

    Current liabilities

    818,230

    482,436

    414,574

    642,761

    637,716

    Non-current liabilities

    355,661

    354,649

    353,912

    355,451

    355,390

    Liabilities

    1,173,891

    837,085

    768,486

    998,212

    993,106

    Stockholders' equity

    1,602,255

    1,690,663

    1,732,300

    1,860,786

    1,858,799

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, August 2017

    Apex: Consolidated income statement, 2Q16 - 2Q17 (NT$k)

    Item

    2Q-2017

    1Q-2017

    4Q-2016

    3Q-2016

    2Q-2016

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Gross sales

    419,801

     

    424,990

     

     

     

     

     

    509,022

     

    Operating revenue

    419,801

    100%

    424,990

    100%

    368,972

    72.5%

    403,241

    79.2%

    509,022

    100%

    Gross profit (loss) from operations

    89,252

    21.3%

    75,548

    17.8%

    89,255

    17.5%

    91,021

    17.9%

    144,414

    28.4%

    Operating expenses

    47,662

    11.4%

    60,894

    14.3%

    56,217

    11%

    55,379

    10.9%

    65,686

    12.9%

    Operating income (loss)

    41,590

    9.9%

    14,654

    3.4%

    33,038

    6.5%

    35,642

    7%

    78,728

    15.5%

    Non-operating expenses and losses

    19,106

    4.6%

    -53,646

    -12.6%

    -144,637

    -28.4%

    -34,016

    -6.7%

    1,175

    0.2%

    Income from continuing operations before income tax

    60,696

    14.5%

    -38,992

    -9.2%

    -111,599

    -21.9%

    1,626

    0.3%

    79,903

    15.7%

    Net income (loss)

    57,277

    13.6%

    -38,992

    -9.2%

    -130,469

    -25.6%

    1,245

    0.2%

    64,908

    12.8%

    Diluted earnings per share (NT$)

    0

     

     

     

    0

     

     

     

    0.6

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, August 2017

  • Apex Biotechnology full profile
Realtime news
  • Ligitek expected to turn profitable in 2017

    LED | 16min ago

  • HY Electronic plans TSE listing

    Bits + chips | 22min ago

Pause
 | 
View more

18-Aug-2017 markets closed

 LastChange

TAIEX (TSE)10321.33-48.04-0.46% 

TSE electronic437.42-2.43-0.55% 

GTSM (OTC)135.34-0.13-0.1% 

OTC electronic197.77-0.04-0.02% 

WCIT 2017
China AMOLED panel capacity expansion forecast, 2016-2020
Global notebook shipment forecast, 2017 and beyond
  • The 10nm competition

    TSMC and Samsung have been competing for clients for the 10nm node.

  • Memory price rally

    DRAM prices have been rising amid tight supply.

  • ASE-SPIL merger

    A proposed merger between Advanced Semiconductor Engineering (ASE) and Siliconware Precision Industries (SPIL) has yet to receive approval from the US...

  • Japan earthquake

    Earthquakes in Japan often cause huge damage. They have had strong impacts on the country's electronics industry.

  • China AMOLED panel capacity expansion forecast, 2016-2020

    This Digitimes Research Special Report examines the China AMOLED industry, focusing on the expansion capacity of the makers, the current implementation plans of major smartphone vendors in the market and the technological hurdles faced by the China makers.

  • Taiwan server shipment forecast and industry analysis, 2017

    Digitimes Research estimates that revenues from sales of server motherboards, servers, storage systems and related network system equipment by Taiwan-based vendors reached NT$555.8 billion in 2016 and the amount is estimated to grow 5.9% on year in 2017.

  • Global notebook shipment forecast, 2017 and beyond

    This Digitimes Special Report examines key factors in the notebook industry, including products, vendors and ODMs, that will affect total shipments in 2017 and through 2021.